Full Text View
Tabular View
No Study Results Posted
Related Studies
Pharmacological Intervention in Diabetic Retinopathy (XAVOT)
This study has been completed.
Study NCT00619034   Information provided by University of Aarhus

First Received on February 7, 2008.   Last Updated on December 28, 2010   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Diabetic Retinopathy
Additional conditions recognized in this trial
Retinal Diseases
More general conditions related to this trial
Cardiovascular Diseases
Diabetes Complications
Diabetes Mellitus
Diabetic Angiopathies
Endocrine System Diseases
Eye Diseases
Vascular Diseases
Interventions listed in this trial
Diclofenac
Dorzolamide
Additional drug interventions recognized in this trial
Latanoprost
Tetrahydrozoline
More general drug interventions related to this trial
Analgesics
Analgesics, Non-Narcotic
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Antihypertensive Agents
Antirheumatic Agents
Autonomic Agents
Carbonic Anhydrase Inhibitors
Cardiovascular Agents
Central Nervous System Agents
Cyclooxygenase Inhibitors
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Nasal Decongestants
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Respiratory System Agents
Sensory System Agents
Sympathomimetics
Therapeutic Uses
Vasoconstrictor Agents
Sponsors listed in this trial
University of Aarhus


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services